Patent · US Active

4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof

US10590088B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

Translational Drug Development, LLC · US

Inventors

Tong Wang · Scottsdale, US
Stephen Gately · Palatine, US

Key dates

Filing date	Oct 16, 2018
Grant date	Mar 17, 2020
Priority date	—
Expiry date	Oct 16, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are 4-(benzimidazol-2-ylamino)benzamide derivatives useful in slowing the expansion of cancer cells and methods of synthesizing derivatives of formula 5 or formula 7: wherein R and R′ are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.